LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

TaiDoc Showcases Multi-Parameter Monitoring Systems and Advanced Devices

By LabMedica International staff writers
Posted on 18 Nov 2019
Print article
Image: POCT Hemoglobin A1c (HbA1c) Analyzer TD-4611 (Photo courtesy of TaiDoc Technology)
Image: POCT Hemoglobin A1c (HbA1c) Analyzer TD-4611 (Photo courtesy of TaiDoc Technology)
TaiDoc Technology (New Taipei City, Taiwan) showcased its multi-parameter monitoring systems and advanced devices in the areas of Home Care, Diagnostics, Professional Instrument and TeleHealth System at the MEDICA 2019 Trade Fair held in Düsseldorf, Germany from 18-21st November.

The MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. MEDICA provides the medical device industry with a central market for innovative products and systems that result in an important contribution to the efficiency and quality of patient care. The combination of product shows with international congresses, forums, as well as expert workshops, and the exchange of professional views make MEDICA a meeting point for international professionals from various fields in the medical sector.

TaiDoc is dedicating to manufacturing and marketing premium medical devices to improve people’s health and the quality of life. The healthcare products manufacturer focuses on providing complete solutions covering Home Care, Diagnostics, Professional Instrument and TeleHealth System.

At the 2019 edition of MEDICA, TaiDoc showcased its blood glucose monitoring systems which use its patented 2+2 (2 enzymes + 2 signals) technology which uses two different wells on the strips to detect HTC value by AC signal and glucose value by DC signal. TaiDoc also highlighted its multi-parameter monitoring systems that provide six parameters - glucose, ketone, cholesterol, uric acid, lactate and Hemoglobin A1c (HbA1c) - for comprehensive patient care. Other advanced devices showcased by TaiDoc at the event included blood pressure monitors, nebulizers, thermometers, lancing devices and lancets.

Related Links:
TaiDoc Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more